Paridiprubart (anti-TLR4) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191908-1MG / 1MG
CAS:2641646-59-3
Paridiprubart (anti-TLR4) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191908-5MG / 5MG
CAS:2641646-59-3
Befovacimab (anti-TFPI) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191914-100ΜG / 100ΜG
CAS:2156634-62-5
Befovacimab (anti-TFPI) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191914-10MG / 10MG
CAS:2156634-62-5
Befovacimab (anti-TFPI) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191914-1MG / 1MG
CAS:2156634-62-5
Befovacimab (anti-TFPI) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191914-5MG / 5MG
CAS:2156634-62-5
Bapotulimab (anti-ILDR2) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191915-100ΜG / 100ΜG
CAS:2359413-58-2
Bapotulimab (anti-ILDR2) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191915-10MG / 10MG
CAS:2359413-58-2
Bapotulimab (anti-ILDR2) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191915-1MG / 1MG
CAS:2359413-58-2
Bapotulimab (anti-ILDR2) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191915-5MG / 5MG
CAS:2359413-58-2
NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-100ΜG / 100ΜG
CAS:2649854-92-0
NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-10MG / 10MG
CAS:2649854-92-0
NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-1MG / 1MG
CAS:2649854-92-0
NIS-793 (anti-TGFb1) 無載體, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191917-5MG / 5MG
CAS:2649854-92-0
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-100ΜG / 100ΜG
CAS:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-10MG / 10MG
CAS:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-1MG / 1MG
CAS:2427667-03-4
Quisovalimab (anti-TNFSF14) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191918-5MG / 5MG
CAS:2427667-03-4
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-100ΜG / 100ΜG
CAS:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-10MG / 10MG
CAS:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-1MG / 1MG
CAS:2428381-56-8
Manfidokimab (anti-IL-4Ra) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191921-5MG / 5MG
CAS:2428381-56-8
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-100ΜG / 100ΜG
CAS:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-10MG / 10MG
CAS:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-1MG / 1MG
CAS:2428381-55-7
Ligufalimab (anti-CD47) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191922-5MG / 5MG
CAS:2428381-55-7
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-100ΜG / 100ΜG
CAS:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-10MG / 10MG
CAS:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-1MG / 1MG
CAS:2304800-90-4
Ebronucimab (anti-PCSK9) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191923-5MG / 5MG
CAS:2304800-90-4
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-100ΜG / 100ΜG
CAS:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-10MG / 10MG
CAS:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-1MG / 1MG
CAS:1826020-80-7
Gatralimab (anti-CD52) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191927-5MG / 5MG
CAS:1826020-80-7